Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL1149566

N.NCCCCn1cnc(-c2cccnc2)c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.63
CYP2C19 P33261 6/20 0.63
CYP2C9 P11712 5/20 0.63
CYP2B6 P20813 5/20 0.63
CYP2E1 P05181 4/20 0.63
CYP3A4 P08684 3/20 0.63
CYP2D6 P10635 3/20 0.58
LOXL2 Q9Y4K0 1/20 0.46
TLR8 Q9NR97 1/20 0.44
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HRH1 P35367 2/20 0.40
NAMPT P43490 2/20 0.40
CAMK2D Q13557 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
PTK2 Q05397 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL708867 0.99 CYP2A6 (0.65) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL31282496 0.99 CYP2A6 (0.65) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
Hydrochloric Acid SCHEMBL1149529 0.97 CYP2A6 (0.63) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL2386354 0.97 CYP2A6 (0.63) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL1987084 0.94 CYP2A6 (0.67) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL1132959 0.89 CYP2A6 (0.70) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL5717914 0.85 CYP2A6 (0.65) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL13750026 0.85 CYP2C9 (0.74) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL6423436 0.85 CYP2A6 (0.65) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1
SCHEMBL5014459 0.85 CYP2A6 (0.68) CYP2A6CYP2C19CYP2C9CYP2B6CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110040078-A1 PROCESS FOR THE PRODUCTION OF TELITHROMYCIN Wolf, Siegfried (AT) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110040078-A1 PROCESS FOR THE PRODUCTION OF TELITHROMYCIN TREH, EEF2, TCERG1 CYP2A6 431/4885CYP2C19 110/4885CYP2C9 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.